Valeant Expands in Ophthalmology with Acquisition of QLT’s Visudyne ®
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 10 (Table of Contents)
Published: 12 Oct-2012
DOI: 10.3833/pdr.v2012.i10.1819 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Valeant Pharmaceuticals has acquired Visudyne® (verteporfin for injection), a photosensitiser used in the treatment of certain forms of wet age-related macular degeneration (AMD), from Canadian biotech QLT for a potential US$132...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS